Imbruvica and Pneumonia - a phase IV clinical study of FDA data
Summary:
Pneumonia is found among people who take Imbruvica, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Imbruvica and have Pneumonia. It is created by eHealthMe based on reports of 50,071 people who have side effects when taking Imbruvica from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
50,071 people reported to have side effects when taking Imbruvica.
Among them, 2,428 people (4.85%) have Pneumonia.
What is Imbruvica?
Imbruvica has active ingredients of ibrutinib. It is often used in chronic lymphocytic leukemia (cll). eHealthMe is studying from 50,141 Imbruvica users for its effectiveness, alternative drugs and more.
What is Pneumonia?
Pneumonia is found to be associated with 4,226 drugs and 4,522 conditions by eHealthMe.
Number of Imbruvica and Pneumonia reports submitted per year:
Time on Imbruvica when people have Pneumonia *:
Gender of people who have Pneumonia when taking Imbruvica*:
Age of people who have Pneumonia when taking Imbruvica *:
Common drugs people take besides Imbruvica *:
Common side effects people have besides Pneumonia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Imbruvica and have Pneumonia?
Check whether Pneumonia is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Pneumonia and when was it recovered:
Expand to all the drugs that have ingredients of ibrutinib:
- Pneumonia and drugs with ingredients of ibrutinib (3,151 reports)
Alternative drugs to, pros and cons of Imbruvica:
- Imbruvica (50,141 reports)
Common Imbruvica side effects:
- Death: 5,356 reports
- Fatigue (feeling of tiredness): 4,151 reports
- Diarrhea: 3,399 reports
- Head injury: 2,818 reports
- Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2,600 reports
- Pneumonia: 2,428 reports
- Weakness: 2,420 reports
- Rashes (redness): 2,329 reports
Browse all side effects of Imbruvica:
a b c d e f g h i j k l m n o p q r s t u v w x y zPneumonia treatments and more:
- Pneumonia (371,728 reports)
COVID vaccines that are related to Pneumonia:
- Pneumonia in Moderna COVID Vaccine
- Pneumonia in Pfizer BioNTech Covid Vaccine
- Pneumonia in Johnson and Johnson Covid Vaccine
Common drugs associated with Pneumonia:
- Prednisone: 28,999 reports
- Methotrexate: 22,271 reports
- Aspirin: 18,784 reports
- Revlimid: 16,950 reports
- Humira: 15,707 reports
- Enbrel: 14,083 reports
- Furosemide: 13,078 reports
- Omeprazole: 12,662 reports
- Lasix: 11,196 reports
- Spiriva: 10,091 reports
All the drugs that are associated with Pneumonia:
- Pneumonia (4,226 drugs)
Common conditions associated with Pneumonia:
- Rheumatoid arthritis: 33,649 reports
- Multiple myeloma: 25,351 reports
- High blood pressure: 15,652 reports
- Asthma: 13,765 reports
- Multiple sclerosis: 12,898 reports
- Primary pulmonary hypertension: 12,732 reports
All the conditions that are associated with Pneumonia:
- Pneumonia (4,522 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ibrutinib (the active ingredients of Imbruvica) and Imbruvica (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Micardis and Herpes Zoster Oticus - 21 seconds ago
- Dandelion and Insomnia - 22 seconds ago
- Phentermine Hydrochloride and Dizziness - 31 seconds ago
- Lansoprazole and Hepatobiliary Infection - 42 seconds ago
- Tussionex Pennkinetic and Haematocrit - 45 seconds ago
- Skelaxin and Diverticulum Intestinal - 50 seconds ago
- Halcion and Pyromania - a minute ago
- Polyethylene Glycol 3350 And Electrolytes and Impaired Work Ability - a minute ago
- Acitretin and Paronychia - a minute ago
- Gravol and Anaphylaxis - a minute ago